"oncotarget" meaning in English

{
  "etymology_templates": [
    {
      "args": {
        "1": "en",
        "2": "onco",
        "3": "target"
      },
      "expansion": "onco- + target",
      "name": "prefix"
    }
  ],
  "etymology_text": "onco- + target",
  "forms": [
    {
      "form": "oncotargets",
      "tags": [
        "plural"
      ]
    }
  ],
  "head_templates": [
    {
      "args": {},
      "expansion": "oncotarget (plural oncotargets)",
      "name": "en-noun"
    }
  ],
  "lang": "English",
  "lang_code": "en",
  "pos": "noun",
  "senses": [
    {
      "categories": [
        {
          "kind": "other",
          "name": "English entries with incorrect language header",
          "parents": [
            "Entries with incorrect language header",
            "Entry maintenance"
          ],
          "source": "w"
        },
        {
          "kind": "other",
          "name": "English terms prefixed with onco-",
          "parents": [],
          "source": "w"
        },
        {
          "kind": "topical",
          "langcode": "en",
          "name": "Medicine",
          "orig": "en:Medicine",
          "parents": [
            "Biology",
            "Sciences",
            "All topics",
            "Fundamental"
          ],
          "source": "w"
        }
      ],
      "examples": [
        {
          "ref": "2015 April 12, Meichun Hu et al., “Lycorine is a novel inhibitor of the growth and metastasis of hormone-refractory prostate cancer”, in Oncotarget, volume 6",
          "text": "Many researches confirm STAT3 as a causal role in oncogenesis, and provide validation of STAT3 as an oncotarget for cancer drug discovery [ 18 ].",
          "type": "quotation"
        }
      ],
      "glosses": [
        "The target of a cancer therapy"
      ],
      "id": "en-oncotarget-en-noun-wd4sU20F",
      "links": [
        [
          "medicine",
          "medicine"
        ],
        [
          "target",
          "target"
        ],
        [
          "cancer",
          "cancer"
        ],
        [
          "therapy",
          "therapy"
        ]
      ],
      "raw_glosses": [
        "(medicine) The target of a cancer therapy"
      ],
      "topics": [
        "medicine",
        "sciences"
      ]
    }
  ],
  "word": "oncotarget"
}

{
  "etymology_templates": [
    {
      "args": {
        "1": "en",
        "2": "onco",
        "3": "target"
      },
      "expansion": "onco- + target",
      "name": "prefix"
    }
  ],
  "etymology_text": "onco- + target",
  "forms": [
    {
      "form": "oncotargets",
      "tags": [
        "plural"
      ]
    }
  ],
  "head_templates": [
    {
      "args": {},
      "expansion": "oncotarget (plural oncotargets)",
      "name": "en-noun"
    }
  ],
  "lang": "English",
  "lang_code": "en",
  "pos": "noun",
  "senses": [
    {
      "categories": [
        "English countable nouns",
        "English entries with incorrect language header",
        "English lemmas",
        "English nouns",
        "English terms prefixed with onco-",
        "English terms with quotations",
        "en:Medicine"
      ],
      "examples": [
        {
          "ref": "2015 April 12, Meichun Hu et al., “Lycorine is a novel inhibitor of the growth and metastasis of hormone-refractory prostate cancer”, in Oncotarget, volume 6",
          "text": "Many researches confirm STAT3 as a causal role in oncogenesis, and provide validation of STAT3 as an oncotarget for cancer drug discovery [ 18 ].",
          "type": "quotation"
        }
      ],
      "glosses": [
        "The target of a cancer therapy"
      ],
      "links": [
        [
          "medicine",
          "medicine"
        ],
        [
          "target",
          "target"
        ],
        [
          "cancer",
          "cancer"
        ],
        [
          "therapy",
          "therapy"
        ]
      ],
      "raw_glosses": [
        "(medicine) The target of a cancer therapy"
      ],
      "topics": [
        "medicine",
        "sciences"
      ]
    }
  ],
  "word": "oncotarget"
}